Ganjapreneur report In a federal indictment unsealed Tuesday, a pair of executives for New Jersey cannabis company CanaFarma Corp. are accused of defrauding investors out of at least $4 million.     Vitaly Fargesen, CanaFarma senior vice president of strategic planning, and Igor Palatnik, the company’s senior vice president of product acquisition, are facing multiple counts of securities fraud and … Continue reading New Jersey: CanaFarma execs face multiple counts of securities fraud and wire fraud.